Trading Report: The Macquarie Reaffirms “Neutral” Rating for Inmarsat Plc (ISAT)

The Macquarie Reaffirms “Neutral” Rating for Inmarsat Plc (ISAT)

Inmarsat Plc (LON:ISAT)‘s stock had its “neutral” rating reaffirmed by equities researchers at Macquarie in a research report issued to clients and investors on Monday. They presently have a GBX 800 ($10.44) price target on the stock. Macquarie’s price target points to a potential upside of 13.72% from the stock’s current price.

Several other analysts have also weighed in on the stock. Jefferies Group reaffirmed a “buy” rating and set a GBX 1,245 ($16.25) price objective on shares of Inmarsat Plc in a report on Monday. Barclays PLC decreased their price target on shares of Inmarsat Plc from GBX 840 ($10.96) to GBX 745 ($9.72) and set an “underweight” rating on the stock in a research note on Monday, October 3rd. Goldman Sachs Group Inc. initiated coverage on shares of Inmarsat Plc in a research note on Wednesday, August 10th. They set a “buy” rating and a GBX 1,090 ($14.23) price target on the stock. Haitong Bank cut shares of Inmarsat Plc to a “neutral” rating and set a GBX 880 ($11.49) price target on the stock. in a research note on Tuesday, August 9th. Finally, Credit Suisse Group AG reissued an “outperform” rating and set a GBX 1,060 ($13.84) price target on shares of Inmarsat Plc in a research note on Thursday, August 4th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company’s stock. Inmarsat Plc has a consensus rating of “Hold” and a consensus price target of GBX 999.40 ($13.05).

Shares of Inmarsat Plc (LON:ISAT) opened at 710.00 on Monday. The firm’s 50-day moving average is GBX 747.85 and its 200 day moving average is GBX 809.80. The firm’s market capitalization is GBX 3.19 billion. Inmarsat Plc has a 52 week low of GBX 663.50 and a 52 week high of GBX 1,153.00.

10/10/macquarie-reaffirms-neutral-rating-for-inmarsat-plc-isat.html

Related posts

Leave a Comment